Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 3 | 2022 | 235 | 1.730 |
Why?
|
Adoption | 7 | 2017 | 10 | 1.590 |
Why?
|
Eating | 3 | 2021 | 166 | 1.400 |
Why?
|
Parents | 6 | 2020 | 329 | 1.390 |
Why?
|
Hawaii | 24 | 2023 | 1929 | 1.360 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2024 | 864 | 1.310 |
Why?
|
Health Status | 3 | 2022 | 380 | 1.300 |
Why?
|
Oral Health | 2 | 2020 | 68 | 1.290 |
Why?
|
Health Services Accessibility | 3 | 2022 | 560 | 1.240 |
Why?
|
Humans | 77 | 2024 | 37093 | 1.220 |
Why?
|
Students, Nursing | 3 | 2021 | 39 | 1.110 |
Why?
|
Adult | 43 | 2024 | 11712 | 1.090 |
Why?
|
Myocardial Infarction | 2 | 2021 | 225 | 1.080 |
Why?
|
Female | 57 | 2023 | 20969 | 1.040 |
Why?
|
Health Status Disparities | 3 | 2020 | 642 | 1.040 |
Why?
|
Male | 49 | 2024 | 20025 | 1.020 |
Why?
|
Diabetes Mellitus | 5 | 2021 | 485 | 1.010 |
Why?
|
Feeding Behavior | 2 | 2020 | 454 | 1.010 |
Why?
|
Depression | 6 | 2020 | 712 | 1.000 |
Why?
|
Quality of Life | 2 | 2020 | 481 | 0.980 |
Why?
|
Osteoarthritis | 2 | 2021 | 20 | 0.970 |
Why?
|
Education, Nursing, Baccalaureate | 2 | 2014 | 24 | 0.960 |
Why?
|
Poverty | 4 | 2023 | 348 | 0.910 |
Why?
|
Social Identification | 1 | 2023 | 58 | 0.880 |
Why?
|
United States | 17 | 2023 | 4223 | 0.870 |
Why?
|
Hyperkalemia | 1 | 2022 | 15 | 0.870 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 169 | 0.840 |
Why?
|
Biomedical Research | 2 | 2023 | 400 | 0.820 |
Why?
|
Cross-Sectional Studies | 16 | 2024 | 2721 | 0.780 |
Why?
|
Middle Aged | 29 | 2024 | 10129 | 0.760 |
Why?
|
Body Mass Index | 5 | 2019 | 854 | 0.760 |
Why?
|
Child | 14 | 2022 | 3131 | 0.760 |
Why?
|
Students | 3 | 2023 | 519 | 0.750 |
Why?
|
Mental Health Services | 2 | 2020 | 118 | 0.740 |
Why?
|
Aged | 22 | 2021 | 6741 | 0.740 |
Why?
|
Medicaid | 2 | 2018 | 109 | 0.740 |
Why?
|
Mothers | 5 | 2019 | 181 | 0.730 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2020 | 4 | 0.730 |
Why?
|
Stroke | 2 | 2021 | 286 | 0.720 |
Why?
|
Emotions | 2 | 2023 | 220 | 0.720 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 101 | 0.710 |
Why?
|
Adolescent | 17 | 2021 | 5363 | 0.690 |
Why?
|
Young Adult | 20 | 2022 | 4268 | 0.690 |
Why?
|
Absenteeism | 1 | 2019 | 11 | 0.680 |
Why?
|
Prevalence | 7 | 2022 | 1455 | 0.670 |
Why?
|
Cognition | 2 | 2023 | 398 | 0.670 |
Why?
|
Exercise | 3 | 2020 | 613 | 0.620 |
Why?
|
Hospital Mortality | 2 | 2018 | 187 | 0.600 |
Why?
|
Referral and Consultation | 1 | 2018 | 117 | 0.590 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2016 | 10 | 0.560 |
Why?
|
Hydrogen Sulfide | 1 | 2016 | 39 | 0.530 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 26 | 0.520 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2015 | 7 | 0.520 |
Why?
|
Risk Adjustment | 1 | 2015 | 17 | 0.520 |
Why?
|
Curriculum | 2 | 2014 | 265 | 0.520 |
Why?
|
Central Nervous System | 1 | 2016 | 135 | 0.510 |
Why?
|
Air Pollutants | 1 | 2016 | 94 | 0.510 |
Why?
|
Nutrition Surveys | 4 | 2021 | 242 | 0.510 |
Why?
|
Empathy | 1 | 2014 | 28 | 0.490 |
Why?
|
Socioeconomic Factors | 9 | 2020 | 1067 | 0.480 |
Why?
|
Internship, Nonmedical | 1 | 2014 | 2 | 0.480 |
Why?
|
Environmental Exposure | 1 | 2016 | 216 | 0.470 |
Why?
|
Papillomavirus Infections | 3 | 2024 | 336 | 0.460 |
Why?
|
Depressive Disorder | 2 | 2012 | 174 | 0.450 |
Why?
|
Leadership | 1 | 2014 | 76 | 0.450 |
Why?
|
Hospitalization | 3 | 2022 | 388 | 0.430 |
Why?
|
Spectrum Analysis, Raman | 4 | 2022 | 88 | 0.410 |
Why?
|
Retrospective Studies | 10 | 2022 | 2026 | 0.400 |
Why?
|
Colonography, Computed Tomographic | 1 | 2010 | 23 | 0.380 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2010 | 18 | 0.380 |
Why?
|
Aged, 80 and over | 10 | 2021 | 2379 | 0.370 |
Why?
|
Medicare | 4 | 2021 | 195 | 0.370 |
Why?
|
Healthcare Disparities | 5 | 2018 | 494 | 0.360 |
Why?
|
Esophageal and Gastric Varices | 1 | 2009 | 7 | 0.360 |
Why?
|
Preoperative Care | 1 | 2009 | 26 | 0.350 |
Why?
|
Endoscopy | 1 | 2009 | 14 | 0.350 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2009 | 27 | 0.350 |
Why?
|
Liver Transplantation | 1 | 2009 | 30 | 0.340 |
Why?
|
Risk Factors | 7 | 2021 | 3562 | 0.340 |
Why?
|
Biosensing Techniques | 2 | 2022 | 86 | 0.330 |
Why?
|
Longevity | 2 | 2023 | 147 | 0.330 |
Why?
|
Community Networks | 2 | 2020 | 108 | 0.330 |
Why?
|
Caveolae | 1 | 2008 | 9 | 0.330 |
Why?
|
Early Detection of Cancer | 4 | 2023 | 336 | 0.330 |
Why?
|
Diet Surveys | 2 | 2020 | 101 | 0.320 |
Why?
|
Anal Canal | 2 | 2019 | 30 | 0.320 |
Why?
|
Intention | 3 | 2024 | 94 | 0.320 |
Why?
|
Dental Care | 2 | 2020 | 26 | 0.320 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2008 | 51 | 0.320 |
Why?
|
Reproducibility of Results | 6 | 2023 | 935 | 0.310 |
Why?
|
Child, Preschool | 6 | 2018 | 1418 | 0.310 |
Why?
|
Polychlorinated Biphenyls | 1 | 2008 | 43 | 0.310 |
Why?
|
Physicians | 2 | 2020 | 163 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 481 | 0.300 |
Why?
|
Mutation | 2 | 2017 | 1095 | 0.290 |
Why?
|
Parenting | 3 | 2017 | 127 | 0.290 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 628 | 0.290 |
Why?
|
Energy Intake | 3 | 2020 | 170 | 0.290 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2006 | 5 | 0.290 |
Why?
|
Resuscitation | 2 | 2016 | 17 | 0.280 |
Why?
|
Fathers | 2 | 2024 | 33 | 0.270 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 253 | 0.270 |
Why?
|
Mass Screening | 4 | 2023 | 462 | 0.270 |
Why?
|
Health Services Research | 2 | 2018 | 148 | 0.270 |
Why?
|
Patient Care Team | 2 | 2016 | 47 | 0.270 |
Why?
|
Interprofessional Relations | 2 | 2016 | 54 | 0.270 |
Why?
|
Chickens | 1 | 2006 | 133 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 404 | 0.260 |
Why?
|
Endothelial Cells | 1 | 2008 | 308 | 0.250 |
Why?
|
Chronic Disease | 4 | 2022 | 484 | 0.250 |
Why?
|
Sodium, Dietary | 2 | 2021 | 27 | 0.240 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 515 | 0.240 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2023 | 10 | 0.230 |
Why?
|
Health | 1 | 2023 | 30 | 0.230 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 198 | 0.220 |
Why?
|
Data Mining | 1 | 2023 | 23 | 0.220 |
Why?
|
Civil Defense | 1 | 2023 | 11 | 0.220 |
Why?
|
Nurses | 1 | 2023 | 48 | 0.210 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 16 | 0.210 |
Why?
|
Social Isolation | 1 | 2022 | 29 | 0.210 |
Why?
|
Databases, Factual | 1 | 2023 | 291 | 0.210 |
Why?
|
Culture | 1 | 2023 | 173 | 0.210 |
Why?
|
Cultural Competency | 1 | 2023 | 131 | 0.210 |
Why?
|
Research Personnel | 1 | 2023 | 155 | 0.210 |
Why?
|
Immunoassay | 2 | 2022 | 61 | 0.210 |
Why?
|
Ambulatory Care | 1 | 2022 | 75 | 0.210 |
Why?
|
Inpatients | 1 | 2022 | 74 | 0.210 |
Why?
|
Patient Participation | 1 | 2022 | 75 | 0.200 |
Why?
|
Mother-Child Relations | 2 | 2012 | 59 | 0.200 |
Why?
|
Papillomavirus Vaccines | 1 | 2024 | 151 | 0.200 |
Why?
|
Metal Nanoparticles | 2 | 2022 | 183 | 0.200 |
Why?
|
Anus Neoplasms | 2 | 2019 | 49 | 0.190 |
Why?
|
Fruit | 2 | 2020 | 173 | 0.190 |
Why?
|
Patient Readmission | 1 | 2022 | 73 | 0.190 |
Why?
|
Genotype | 4 | 2023 | 730 | 0.190 |
Why?
|
Family Characteristics | 2 | 2019 | 108 | 0.190 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 43 | 0.190 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2020 | 56 | 0.190 |
Why?
|
Proteomics | 1 | 2023 | 325 | 0.190 |
Why?
|
Health Education, Dental | 1 | 2020 | 5 | 0.180 |
Why?
|
Nutrition Policy | 1 | 2021 | 70 | 0.180 |
Why?
|
Diet Records | 2 | 2018 | 60 | 0.180 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 61 | 0.180 |
Why?
|
Oseltamivir | 1 | 2019 | 7 | 0.180 |
Why?
|
Body Fluids | 1 | 2019 | 17 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 277 | 0.170 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 19 | 0.170 |
Why?
|
Signal Transduction | 1 | 2008 | 1908 | 0.170 |
Why?
|
Nebulizers and Vaporizers | 1 | 2019 | 19 | 0.170 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 63 | 0.170 |
Why?
|
Dietary Proteins | 3 | 2017 | 32 | 0.170 |
Why?
|
Managed Care Programs | 1 | 2019 | 38 | 0.170 |
Why?
|
Infant | 4 | 2018 | 1046 | 0.170 |
Why?
|
Immunoconjugates | 1 | 2018 | 7 | 0.170 |
Why?
|
Trauma Centers | 2 | 2016 | 79 | 0.170 |
Why?
|
Clinical Competence | 2 | 2023 | 130 | 0.170 |
Why?
|
Public Assistance | 1 | 2019 | 27 | 0.160 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 208 | 0.160 |
Why?
|
Interviews as Topic | 1 | 2020 | 381 | 0.160 |
Why?
|
Saliva | 1 | 2019 | 107 | 0.160 |
Why?
|
Human papillomavirus 16 | 1 | 2018 | 35 | 0.160 |
Why?
|
Preventive Dentistry | 1 | 2018 | 3 | 0.160 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 68 | 0.160 |
Why?
|
Antibodies | 1 | 2018 | 141 | 0.160 |
Why?
|
Leukocytes | 1 | 2018 | 72 | 0.160 |
Why?
|
Precancerous Conditions | 1 | 2019 | 82 | 0.160 |
Why?
|
Oral Hygiene | 1 | 2018 | 17 | 0.160 |
Why?
|
Health Expenditures | 1 | 2018 | 32 | 0.150 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 24 | 0.150 |
Why?
|
Doxycycline | 1 | 2017 | 30 | 0.150 |
Why?
|
Risk Assessment | 2 | 2018 | 753 | 0.150 |
Why?
|
Family | 1 | 2019 | 173 | 0.150 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2017 | 5 | 0.150 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 75 | 0.150 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 17 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 14 | 0.150 |
Why?
|
Postpartum Hemorrhage | 1 | 2017 | 10 | 0.150 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 18 | 0.150 |
Why?
|
Breast Feeding | 1 | 2019 | 113 | 0.150 |
Why?
|
Qualitative Research | 1 | 2020 | 446 | 0.150 |
Why?
|
HIV Seropositivity | 1 | 2019 | 190 | 0.150 |
Why?
|
Dental Caries | 1 | 2018 | 57 | 0.150 |
Why?
|
Schools | 1 | 2019 | 260 | 0.150 |
Why?
|
Communication Barriers | 1 | 2017 | 56 | 0.140 |
Why?
|
Health Services for the Aged | 1 | 2016 | 20 | 0.140 |
Why?
|
Parent-Child Relations | 1 | 2017 | 110 | 0.140 |
Why?
|
Microcephaly | 1 | 2016 | 19 | 0.140 |
Why?
|
Stomatognathic Diseases | 1 | 2016 | 3 | 0.140 |
Why?
|
Obstetric Labor, Premature | 1 | 2016 | 13 | 0.140 |
Why?
|
Food Preferences | 1 | 2017 | 73 | 0.140 |
Why?
|
Sleep Stages | 1 | 2016 | 6 | 0.140 |
Why?
|
Follow-Up Studies | 3 | 2018 | 974 | 0.140 |
Why?
|
Nursing Staff, Hospital | 1 | 2016 | 13 | 0.140 |
Why?
|
Primary Health Care | 1 | 2019 | 294 | 0.140 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 27 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 142 | 0.140 |
Why?
|
Body Weight | 1 | 2018 | 434 | 0.140 |
Why?
|
Vaccination | 3 | 2024 | 288 | 0.140 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 38 | 0.140 |
Why?
|
Critical Care | 1 | 2016 | 41 | 0.140 |
Why?
|
Respiratory Function Tests | 1 | 2016 | 55 | 0.140 |
Why?
|
Mycobacterium tuberculosis | 1 | 2017 | 90 | 0.140 |
Why?
|
Sleep Deprivation | 1 | 2016 | 26 | 0.140 |
Why?
|
Pregnancy | 5 | 2022 | 1549 | 0.130 |
Why?
|
Heterozygote | 2 | 2018 | 93 | 0.130 |
Why?
|
Adolescent Behavior | 1 | 2018 | 253 | 0.130 |
Why?
|
Brain Ischemia | 1 | 2018 | 184 | 0.130 |
Why?
|
Disease Progression | 1 | 2018 | 601 | 0.130 |
Why?
|
Patient Compliance | 1 | 2017 | 212 | 0.130 |
Why?
|
Pre-Eclampsia | 1 | 2016 | 61 | 0.130 |
Why?
|
Professional Role | 1 | 2015 | 40 | 0.130 |
Why?
|
Diet | 2 | 2022 | 801 | 0.130 |
Why?
|
Needs Assessment | 1 | 2016 | 170 | 0.130 |
Why?
|
Electroencephalography | 1 | 2016 | 116 | 0.130 |
Why?
|
Delivery of Health Care | 1 | 2018 | 276 | 0.130 |
Why?
|
Reference Values | 1 | 2015 | 212 | 0.130 |
Why?
|
Asthma | 1 | 2019 | 380 | 0.120 |
Why?
|
Confusion | 1 | 2014 | 4 | 0.120 |
Why?
|
Arthroplasty | 1 | 2014 | 3 | 0.120 |
Why?
|
Antibodies, Viral | 1 | 2016 | 262 | 0.120 |
Why?
|
Communication | 1 | 2016 | 180 | 0.120 |
Why?
|
Pain, Postoperative | 1 | 2014 | 21 | 0.120 |
Why?
|
Age Factors | 2 | 2021 | 1033 | 0.120 |
Why?
|
Nursing Evaluation Research | 1 | 2014 | 12 | 0.120 |
Why?
|
Nursing Education Research | 1 | 2014 | 14 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 767 | 0.120 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 385 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2018 | 885 | 0.120 |
Why?
|
Health Behavior | 1 | 2018 | 537 | 0.120 |
Why?
|
Eosinophils | 1 | 2013 | 20 | 0.110 |
Why?
|
Incidence | 2 | 2019 | 922 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2019 | 583 | 0.110 |
Why?
|
Pilot Projects | 2 | 2016 | 661 | 0.110 |
Why?
|
Health Promotion | 1 | 2019 | 653 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 1103 | 0.110 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 441 | 0.110 |
Why?
|
Leucine | 1 | 2012 | 29 | 0.110 |
Why?
|
Analgesics, Opioid | 1 | 2014 | 197 | 0.110 |
Why?
|
Milk Proteins | 1 | 2012 | 29 | 0.110 |
Why?
|
Comorbidity | 3 | 2020 | 623 | 0.110 |
Why?
|
Personality | 1 | 2012 | 42 | 0.100 |
Why?
|
Personal Satisfaction | 1 | 2012 | 64 | 0.100 |
Why?
|
Stem Cells | 1 | 2013 | 141 | 0.100 |
Why?
|
Nitrogen | 1 | 2012 | 71 | 0.100 |
Why?
|
Prospective Studies | 2 | 2017 | 1378 | 0.100 |
Why?
|
Body Composition | 1 | 2012 | 162 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 643 | 0.100 |
Why?
|
Appetite Regulation | 1 | 2010 | 9 | 0.100 |
Why?
|
MutS Homolog 2 Protein | 1 | 2010 | 31 | 0.090 |
Why?
|
Resistance Training | 1 | 2010 | 18 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 93 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 92 | 0.090 |
Why?
|
Colonoscopy | 1 | 2010 | 104 | 0.090 |
Why?
|
Ligation | 1 | 2009 | 10 | 0.090 |
Why?
|
Medical Audit | 1 | 2009 | 25 | 0.090 |
Why?
|
Colonic Polyps | 1 | 2010 | 67 | 0.090 |
Why?
|
Adenoma | 1 | 2010 | 89 | 0.090 |
Why?
|
Waiting Lists | 1 | 2009 | 36 | 0.090 |
Why?
|
Overweight | 1 | 2012 | 247 | 0.090 |
Why?
|
Insurance Claim Review | 2 | 2020 | 28 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 448 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 190 | 0.080 |
Why?
|
Sex Factors | 1 | 2012 | 898 | 0.080 |
Why?
|
Time Factors | 2 | 2016 | 1742 | 0.080 |
Why?
|
Gold | 2 | 2022 | 136 | 0.080 |
Why?
|
Universities | 2 | 2023 | 442 | 0.080 |
Why?
|
Enzyme Induction | 1 | 2008 | 53 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2013 | 1518 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2010 | 307 | 0.080 |
Why?
|
Brain | 1 | 2016 | 1346 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2010 | 251 | 0.080 |
Why?
|
Receptors, LDL | 1 | 2008 | 30 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2009 | 210 | 0.080 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2008 | 48 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2009 | 145 | 0.080 |
Why?
|
Mice, Nude | 1 | 2008 | 337 | 0.070 |
Why?
|
MicroRNAs | 1 | 2013 | 426 | 0.070 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2021 | 39 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 539 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2023 | 894 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2009 | 190 | 0.070 |
Why?
|
Logistic Models | 2 | 2022 | 923 | 0.070 |
Why?
|
GATA1 Transcription Factor | 1 | 2006 | 3 | 0.070 |
Why?
|
5' Untranslated Regions | 1 | 2006 | 18 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2018 | 237 | 0.070 |
Why?
|
Odds Ratio | 2 | 2018 | 534 | 0.070 |
Why?
|
Treatment Outcome | 1 | 2009 | 1369 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 1039 | 0.060 |
Why?
|
Binding Sites | 1 | 2006 | 651 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2017 | 286 | 0.060 |
Why?
|
Base Sequence | 1 | 2006 | 997 | 0.060 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 1568 | 0.060 |
Why?
|
Emergencies | 1 | 2023 | 24 | 0.060 |
Why?
|
Animals | 3 | 2013 | 15081 | 0.060 |
Why?
|
Specimen Handling | 1 | 2023 | 56 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2023 | 55 | 0.050 |
Why?
|
Guam | 1 | 2022 | 79 | 0.050 |
Why?
|
Cell Line | 1 | 2006 | 1354 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2008 | 938 | 0.050 |
Why?
|
Gender Identity | 1 | 2023 | 103 | 0.050 |
Why?
|
Papillomaviridae | 1 | 2023 | 127 | 0.050 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 40 | 0.050 |
Why?
|
Self Care | 1 | 2023 | 159 | 0.050 |
Why?
|
Mice | 2 | 2013 | 5913 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 204 | 0.050 |
Why?
|
Seafood | 1 | 2021 | 23 | 0.050 |
Why?
|
Attitude | 1 | 2021 | 104 | 0.050 |
Why?
|
Nose | 1 | 2019 | 15 | 0.040 |
Why?
|
Surface Properties | 1 | 2019 | 130 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2018 | 14 | 0.040 |
Why?
|
Rats | 1 | 2006 | 3483 | 0.040 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 13 | 0.040 |
Why?
|
Biopsy | 1 | 2019 | 164 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 1492 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2017 | 9 | 0.040 |
Why?
|
Japan | 1 | 2018 | 305 | 0.040 |
Why?
|
Income | 1 | 2019 | 140 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 2018 | 33 | 0.040 |
Why?
|
Elastin | 1 | 2017 | 40 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2017 | 48 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2018 | 89 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2018 | 45 | 0.040 |
Why?
|
Isoniazid | 1 | 2017 | 5 | 0.040 |
Why?
|
Rifampin | 1 | 2017 | 4 | 0.040 |
Why?
|
Alleles | 1 | 2018 | 321 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2020 | 322 | 0.040 |
Why?
|
Cameroon | 1 | 2017 | 38 | 0.040 |
Why?
|
Linear Models | 1 | 2018 | 275 | 0.040 |
Why?
|
Philippines | 1 | 2017 | 73 | 0.040 |
Why?
|
Lung Diseases | 1 | 2018 | 61 | 0.040 |
Why?
|
Survival Analysis | 1 | 2018 | 325 | 0.040 |
Why?
|
Garbage | 1 | 2017 | 2 | 0.040 |
Why?
|
Population Surveillance | 1 | 2019 | 238 | 0.040 |
Why?
|
Antitubercular Agents | 1 | 2017 | 28 | 0.040 |
Why?
|
Child Behavior | 1 | 2017 | 78 | 0.040 |
Why?
|
Home Care Services | 1 | 2017 | 33 | 0.040 |
Why?
|
Blood Banks | 1 | 2016 | 10 | 0.040 |
Why?
|
Spirituality | 1 | 2017 | 49 | 0.040 |
Why?
|
Echocardiography | 1 | 2017 | 144 | 0.040 |
Why?
|
Dairy Products | 1 | 2017 | 35 | 0.040 |
Why?
|
Delivery, Obstetric | 1 | 2017 | 40 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 146 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2017 | 87 | 0.040 |
Why?
|
Delirium | 1 | 2016 | 6 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2016 | 82 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 201 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 268 | 0.030 |
Why?
|
Polysomnography | 1 | 2016 | 42 | 0.030 |
Why?
|
Professional Competence | 1 | 2016 | 40 | 0.030 |
Why?
|
Triage | 1 | 2016 | 26 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2016 | 14 | 0.030 |
Why?
|
Critical Illness | 1 | 2016 | 38 | 0.030 |
Why?
|
Equipment Design | 1 | 2016 | 124 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2016 | 59 | 0.030 |
Why?
|
Arousal | 1 | 2016 | 86 | 0.030 |
Why?
|
Minority Health | 1 | 2016 | 88 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 61 | 0.030 |
Why?
|
Video Recording | 1 | 2015 | 32 | 0.030 |
Why?
|
Vegetables | 1 | 2017 | 147 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 562 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2016 | 208 | 0.030 |
Why?
|
Prognosis | 1 | 2018 | 739 | 0.030 |
Why?
|
Algorithms | 1 | 2018 | 465 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 400 | 0.030 |
Why?
|
Education, Nursing, Continuing | 1 | 2014 | 12 | 0.030 |
Why?
|
Decision Making | 1 | 2016 | 203 | 0.030 |
Why?
|
Puerto Rico | 1 | 2019 | 1378 | 0.030 |
Why?
|
Esophagitis | 1 | 2013 | 6 | 0.030 |
Why?
|
HIV-1 | 1 | 2019 | 706 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2018 | 458 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2017 | 540 | 0.030 |
Why?
|
Appetite | 1 | 2012 | 21 | 0.030 |
Why?
|
Personality Inventory | 1 | 2012 | 75 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2013 | 399 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 664 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 623 | 0.020 |
Why?
|
Hunger | 1 | 2010 | 10 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2012 | 168 | 0.020 |
Why?
|
Kinetics | 1 | 2012 | 708 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 108 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2010 | 103 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2012 | 208 | 0.020 |
Why?
|
Physical Fitness | 1 | 2010 | 90 | 0.020 |
Why?
|
Kidney | 1 | 2012 | 337 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 1609 | 0.020 |
Why?
|
Apoptosis | 1 | 2013 | 1398 | 0.020 |
Why?
|